Recent advances in understanding and managing epidermolysis bullosa [version 1; referees: 2 approved]
Epidermolysis bullosa (EB) is a clinically and genetically heterogeneous skin fragility disorder characterized by trauma-induced skin dissociation and the development of painful wounds. So far, mutations in 20 genes have been described as being associated with more than 30 clinical EB subtypes. The...
Main Authors: | Dimitra Kiritsi, Alexander Nyström |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2018-07-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/7-1097/v1 |
Similar Items
-
Case Report: Diagnostic and Therapeutic Challenges in Severe Mechanobullous Epidermolysis Bullosa Acquisita
by: Franziska Schauer, et al.
Published: (2022-04-01) -
Pro‐inflammatory immunity supports fibrosis advancement in epidermolysis bullosa: intervention with Ang‐(1‐7)
by: Rocco Bernasconi, et al.
Published: (2021-10-01) -
Occurrence of autoantibodies against skin proteins in patients with hereditary epidermolysis bullosa predisposes to development of autoimmune blistering disease
by: Saskia Lehr, et al.
Published: (2022-07-01) -
Recent advances in understanding and managing dystonia [version 1; referees: 2 approved]
by: Stephen Tisch
Published: (2018-07-01) -
Recent advances in understanding and managing diverticulitis [version 1; referees: 3 approved]
by: Carola Severi, et al.
Published: (2018-06-01)